T1	HMM 0 28	Short- and long-term effects
T2	HMM 51 83	salivary cortisol concentrations
T3	HMM 323 365	hypothalamic-pituitary-adrenal (HPA) axis.
T4	HMM 406 460	basal diurnal and total secretion of salivary cortisol
T5	HMM 885 902	Salivary cortisol
T6	HMM 1126 1168	assess and compare cortisol concentrations
T7	HMM 1285 1454	impact of age, gender, body mass index (BMI), duration and severity of PD, effects of interventional time-point of the day, and levodopa doses on cortisol concentration.
T8	HMM 1467 1497	median cortisol concentrations
T9	HMM 1630 1653	Cortisol concentrations
T10	HMM 1786 1818	salivary cortisol concentrations
T11	HMM 2022 2045	cortisol concentrations
T12	HMM 2050 2208	age, gender, BMI, time-point for intervention, time interval between anti-parkinson pharmacy intake and sampling, levodopa doses, duration, or severity of PD.
T13	HMM 2221 2253	Diurnal salivary cortisol rhythm
T14	HMM 2266 2298	Salivary cortisol concentrations
T15	HMM 2497 2528	salivary cortisol concentration
